Tara Volkmann, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Unit 3120 Box 52, Dpo, AA 34055 Phone: 619-324-9733 |
Claudia Angelica Mendoza Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2496 Ricker Road, Ft. Bliss, AA 79225 Phone: 915-742-4517 |
News Archive
AbbVie announced that the European Commission has granted marketing authorizations for its all-oral, short-course, interferon-free treatment of VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets). The treatment has been approved with or without ribavirin (RBV) for patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with compensated liver cirrhosis, HIV-1 co-infection, patients on opioid substitution therapy and liver transplant recipients.
ATCC, the premier biological materials resource and standards organization, and iPS Academia Japan, Inc. (Kyoto, Japan) (AJ) today announced a worldwide non-exclusive licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio.
Mucins are large proteins that are secreted on the surface of the gut, and while long regarded as having a role as a barrier to mucosal infection, data to support this theory have been lacking.
Researchers at Lund University in Sweden can now show that a new examination method identifies high-risk plaques in the blood vessels surrounding the heart, that cannot be seen solely with traditional angiograms.
› Verified 9 days ago